M. Warner
Impact in
- Molecular Medicine top 0.1%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antibiotic Resistance in Bacteria 22
-
- Antimicrobial Resistance in Staphylococcus 15
- Co-authors
- David M. Livermore (23 shared papers)Shazad Mushtaq (17 shared papers)Neil Woodford (9 shared papers)Alan P. Johnson (6 shared papers)Mary E. Kaufmann (3 shared papers)Jane F. Turton (2 shared papers)N. Woodford (3 shared papers)D. M. Livermore (3 shared papers)
- Journals
- Journal of Antimicrobial Chemotherapy (21 papers)Clinical Microbiology and Infection (4 papers)International Journal of Antimicrobial Agents (3 papers)Journal of Hospital Infection (2 papers)European Journal of Clinical Microbiology & Infectious Diseases (2 papers)
- Partner nations
- United KingdomFranceNepal
In The Last Decade
M. Warner
37 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 90
- Molecular Medicine 1.8k
- Applied Microbiology and Biotechnology 392
- Endocrinology 579
- Clinical Biochemistry 483
- Pharmacology 834
Countries citing papers authored by M. Warner
This map shows the geographic impact of M. Warner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Warner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Warner more than expected).
Fields of papers citing papers by M. Warner
This network shows the impact of papers produced by M. Warner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Warner. The network helps show where M. Warner may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Warner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 411 | |
| 2 | 2010 | 231 | |
| 3 | 2013 | 225 | |
| 4 | 2010 | 179 | |
| 5 | 2008 | 116 | |
| 6 | 2010 | 111 | |
| 7 | 2004 | 106 | |
| 8 | 2002 | 100 | |
| 9 | 2008 | 95 | |
| 10 | 2004 | 74 | |
| 11 | 2009 | 72 | |
| 12 | 2010 | 71 | |
| 13 | 1996 | 66 | |
| 14 | 2009 | 64 | |
| 15 | 2009 | 53 | |
| 16 | 2012 | 52 | |
| 17 | 2008 | 51 | |
| 18 | 2009 | 44 | |
| 19 | 2008 | 41 | |
| 20 | 2007 | 37 |
About M. Warner
M. Warner is a scholar working on Molecular Medicine, Infectious Diseases, Clinical Biochemistry, Molecular Biology and Endocrinology, having authored 38 papers that have together received 2.5k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (22 papers), Antimicrobial Resistance in Staphylococcus (15 papers), Bacterial Identification and Susceptibility Testing (12 papers), Bacterial biofilms and quorum sensing (7 papers), Pharmaceutical and Antibiotic Environmental Impacts (7 papers), Infections and bacterial resistance (6 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Infective Endocarditis Diagnosis and Management (3 papers). The work is most often cited by research in Molecular Medicine (1.8k citations), Applied Microbiology and Biotechnology (392 citations), Endocrinology (579 citations), Clinical Biochemistry (483 citations) and Pharmacology (834 citations). M. Warner has collaborated with scholars based in United Kingdom, France and Nepal. Frequent co-authors include David M. Livermore, Shazad Mushtaq, Neil Woodford, Alan P. Johnson, Mary E. Kaufmann, Jane F. Turton, N. Woodford, D. M. Livermore, Michel Doumith and Sunil Maharjan. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Clinical Microbiology and Infection, International Journal of Antimicrobial Agents, Journal of Hospital Infection and European Journal of Clinical Microbiology & Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.